| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/31/2007 | WO2006069289A3 Polypeptides having glucoamylase activity and polynucleotides encoding same |
| 05/31/2007 | WO2006004593A3 Method for preventing and treating mast cell mediated diseases |
| 05/31/2007 | WO2005058930A3 Methods for production of recombinant vascular endothelial cell growth inhibitor |
| 05/31/2007 | WO2005003316A3 Rna processing protein complexes and uses thereof |
| 05/31/2007 | WO2004100882A3 Inhibition of drug binding to serum albumin |
| 05/31/2007 | US20070124834 Expression vector comprising nucleotide sequences which code plant regulatory sequences; for use in controlling root length, senecense and/or water and nutrient uptake |
| 05/31/2007 | US20070124832 Bioreactor containing cells expressing glycosyltransferase nucleic acids |
| 05/31/2007 | US20070124830 Plastid genetic engineering via somatic embryogenesis |
| 05/31/2007 | US20070123697 purification from a recombinant human interferon beta-containing culture by performing affinity chromatography and reversed-phase high-performance liquid chromatography |
| 05/31/2007 | US20070123486 Composition for coordinated VEGF and PDGF expression, and methods of use |
| 05/31/2007 | US20070123467 Amniotic-derived peptide and uses thereof |
| 05/31/2007 | US20070123459 IL-17 like molecules and uses thereof |
| 05/31/2007 | US20070123457 Carrier chimeric proteins, targeted carrier chimeric proteins and preparation thereof |
| 05/31/2007 | US20070123456 Novel regulator of endothelial cell function and vessel remodeling |
| 05/31/2007 | US20070122884 Factor VII glycoforms |
| 05/31/2007 | US20070122883 Nucleotide sequences coding orphan receptor component of multimeric complex for use in identifying modulator for prevention and treatment of cell proliferative disorders |
| 05/31/2007 | US20070122882 Gene specifically expressed in postmitotic dopaminergic neuron precursor cells |
| 05/31/2007 | US20070122881 Rhamnose-inducible expression systems and methods |
| 05/31/2007 | US20070122880 Vector for the inducible expression of gene sequences |
| 05/31/2007 | US20070122879 for detecting and treating viral infections in in vitro and in vivo; ligand-binding receptor polypeptides can also be used to block ligand activity in vitro and in vivo; for forming a heterodimeric receptor complex with IL-28R and CRF2-4 |
| 05/31/2007 | US20070122878 Human orphan G protein-coupled receptors |
| 05/31/2007 | US20070122877 T-cell vaccination in the treatment of HIV infection |
| 05/31/2007 | US20070122876 Nucleic acids for enhancing gene expression and use thereof |
| 05/31/2007 | US20070122875 Enzyme for decomposition of sulfated fucan derived from sea cucumber |
| 05/31/2007 | US20070122868 Drug screening; identifying potential biological targets for fungicides and for isolating genes coding for proteins controlling biochemical functions essential to the pathogenesis of the fungus Magnaporthe grisea with respect to rice and barley |
| 05/31/2007 | US20070122866 Protein having PGE2 synthase activity and use thereof |
| 05/31/2007 | US20070122865 Enzymes and enzymic processes |
| 05/31/2007 | US20070122859 Immunoassay for LSD and 2-oxo-3-hydroxy-LSD |
| 05/31/2007 | US20070122851 Novel fluorescent and colored proteins, and polynucleotides that encode these proteins |
| 05/31/2007 | US20070122849 Rhesus monkey P2X7 purinergic receptor and uses thereof |
| 05/31/2007 | US20070122846 Anti-human mitochondrial adenylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disease |
| 05/31/2007 | US20070122807 Posh polypeptides, complexes and related methods |
| 05/31/2007 | US20070122451 Biogically non-degradable peptides, angiostensin converting enzyme inhibitor, drug and functional food |
| 05/31/2007 | US20070122428 Genetically modified cholera toxin (CT-CRM) comprising reduced toxicity and enhanced immunological response for use in preparation of vaccines against parasitic infection |
| 05/31/2007 | US20070122425 fusion protein comprising a periplasmic targeting signal and at least one antimicrobial peptide; use as microbiocides; from Gram negative bacteria transformed host cell; nontoxic and proteolytic non-degradation, simple, inexpensive recovery of the peptide; industrial scale production; on medical devices |
| 05/31/2007 | US20070122423 Derp1 and proderp1 allergen derivatives |
| 05/31/2007 | US20070122422 Sodium-independent small neutral amino acid transporter transporting L- and D- amino acids |
| 05/31/2007 | US20070122421 Flagellin fusion for use in generating vaccines for prevention and treatment of tumors, allergens and nervous system disorders |
| 05/31/2007 | US20070122416 Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use |
| 05/31/2007 | US20070122413 Il-21 antagonists |
| 05/31/2007 | US20070122411 Solid forms of anti-egfr antibodies |
| 05/31/2007 | US20070122408 Fc Labeling for Immunostaining and Immunotargeting |
| 05/31/2007 | US20070122405 Human G-protein chemokine receptor (CCR5) HDGNR10 |
| 05/31/2007 | US20070122404 Humanized immunoglobulin reactive with alpha4beta7 integrin |
| 05/31/2007 | US20070122403 Molecules with extended half-lives, compositions and uses thereof |
| 05/31/2007 | US20070122401 Methods and compositions for modulating telomerase reverse transcriptase (tert) expression |
| 05/31/2007 | US20070122380 Chimeric cytokine of IL-7 and beta-chain of HGF and methods of use |
| 05/31/2007 | DE102005056669A1 Fermentative Herstellung organischer Verbindungen unter Einsatz Dextrin-haltiger Medien Fermentative production of organic compounds using dextrin-containing media |
| 05/31/2007 | CA2630964A1 Antibody treatment of alzheimer's and related diseases |
| 05/31/2007 | CA2628725A1 Production of glycoproteins with reduced o-glycosylation |
| 05/30/2007 | EP1790730A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/30/2007 | EP1790729A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/30/2007 | EP1790728A2 Imaging, diagnosis and treatment of disease |
| 05/30/2007 | EP1790726A2 Modified and stabilized GDF propeptides and uses thereof |
| 05/30/2007 | EP1790720A1 Polypeptide having activity of unsaturating omega3-fatty acid, polynucleotide coding for the polypeptide and use thereof |
| 05/30/2007 | EP1790717A2 Compositions and methods for the identification of lung tumor cells |
| 05/30/2007 | EP1790663A1 Monoclonal antibody(ad5-10) against tumor necrosis factor-related apoptosis-inducing ligand receptor dr5, the producing method and uses thereof |
| 05/30/2007 | EP1790660A2 Heterologous expression of neisserial proteins |
| 05/30/2007 | EP1790659A2 Polypeptides of pseudomonas aeruginosa |
| 05/30/2007 | EP1789571A1 Production of polypeptides |
| 05/30/2007 | EP1789558A1 Sialyltransferases comrising conserved sequence motifs |
| 05/30/2007 | EP1789555A1 Novel regulation protein |
| 05/30/2007 | EP1789530A2 Red microalgae expressing exogenous polypeptides and methods of generating and utilizing same |
| 05/30/2007 | EP1789442A2 Muteins of fibroblast growth factor 21 |
| 05/30/2007 | EP1789441A2 Notch mutations leading to increased receptor signaling |
| 05/30/2007 | EP1789072A2 Prophylactic and therapeutic uses of fgf-20 in radiation protection |
| 05/30/2007 | EP1492878B1 Process for the preparation of a desired erythropoietin glyco-isoform profile |
| 05/30/2007 | EP1311663B1 Claudin polypeptides |
| 05/30/2007 | EP1070758B1 Human stanniocalcin and uses thereof to inhibit adipogenesis |
| 05/30/2007 | EP0975754B1 Osteoprotegerin binding proteins and receptors |
| 05/30/2007 | EP0726954B2 Cytokine antagonists |
| 05/30/2007 | EP0672150B1 Modified kluyveromyces yeasts, their preparation and use |
| 05/30/2007 | CN1973046A Method of producing protein |
| 05/30/2007 | CN1973042A Process for producing dipeptides |
| 05/30/2007 | CN1973037A Process for producing dipeptides or dipeptide derivatives |
| 05/30/2007 | CN1970784A Method for extracting carnosine |
| 05/30/2007 | CN1970783A Process for bio-catalytic preparation of zein peptide in organic medium |
| 05/30/2007 | CN1970571A G-csf analog compositions and methods |
| 05/30/2007 | CN1318603C Method for preparing plant separated protein |
| 05/30/2007 | CN1318595C Methods for producing polypeptides in cyclohexadepsipeptide-deficient cells |
| 05/30/2007 | CN1318590C Human protooncogene KG-20 and protein encoded therein |
| 05/30/2007 | CN1318589C Method for preparing mammal cell kinetin synthetic inhibitory factor |
| 05/30/2007 | CN1318588C Osteoprotegerine |
| 05/30/2007 | CN1318587C Recombination preparation method of amidating Exendin-4 polypeptide |
| 05/30/2007 | CN1318577C Medium for protein-free and serum-free cultivation of cells |
| 05/30/2007 | CN1318448C Recombined full length human brain red element, preparation method and application thereof |
| 05/30/2007 | CN1318446C Transferrin receptor protein of Moraxella |
| 05/30/2007 | CN1318443C Methods for refolding proteins containing free cysteine residues |
| 05/30/2007 | CN1318086C Use of soluble CTLA4 molecule in preparation of medicine composition for treating rheumatic diseases |
| 05/29/2007 | US7223858 Truncated aggrecanase molecules |
| 05/29/2007 | US7223854 Transfecting or infecting cells and culturing; purified polypeptide, for use in diagnosis |
| 05/29/2007 | US7223852 Nucleic acids encoding TRAIN-R: a cysteine rich member of the TNF-receptor family |
| 05/29/2007 | US7223846 Urocortin proteins and uses thereof |
| 05/29/2007 | US7223844 Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by Env-CD4-co-receptor complexes |
| 05/29/2007 | US7223840 Antimicrobial peptide |
| 05/29/2007 | US7223839 Splice variants of the human H3 histamine receptor having deletions of portions of the N-terminal of the wild type H3 receptor; useful in methods for identifying agonists, inverse agonists or antagonists of histamine action at the H3 receptor; therapeutic and diagnostic agents; nervous system disorders |
| 05/29/2007 | US7223836 Peptides for chlamydophila pneumoniae vaccine and diagnosis |
| 05/29/2007 | US7223834 Assays and peptide substrate for determining aggrecan degrading metallo protease activity |
| 05/29/2007 | US7223595 Use of purified Streptomyces griseus trypsin for production of a biomass of cells and viral propagation |
| 05/29/2007 | US7223588 Microorganisms and methods for overproduction of DAHP by cloned Pps gene |